[HTML][HTML] Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: a nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - Elsevier
Abstract Background Randomized Controlled Trials showed that omalizumab exhibited a
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
[PDF][PDF] Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - academia.edu
abstract Background: Randomized Controlled Trials showed that omalizumab exhibited a
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
[HTML][HTML] Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - resmedjournal.com
Abstract Background Randomized Controlled Trials showed that omalizumab exhibited a
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
Long-term" real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - europepmc.org
Background Randomized Controlled Trials showed that omalizumab exhibited a good safety
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …
[PDF][PDF] Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - fair.unifg.it
abstract Background: Randomized Controlled Trials showed that omalizumab exhibited a
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
good safety and tolerability profile in patients with moderate-to-severe asthma. However …
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda, E Minenna… - srp.ro
Background: Randomized Controlled Trials showed that omalizumab exhibited a good
safety and tolerability profile in patients with moderate-to-severe asthma. However, safety …
safety and tolerability profile in patients with moderate-to-severe asthma. However, safety …
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda, E Minenna… - srp.ro
Background: Randomized Controlled Trials showed that omalizumab exhibited a good
safety and tolerability profile in patients with moderate-to-severe asthma. However, safety …
safety and tolerability profile in patients with moderate-to-severe asthma. However, safety …
[引用][C] Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - Respiratory …, 2017 - cir.nii.ac.jp
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A
nine-year study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
nine-year study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma. A nine-year study
D Di Bona, I Fiorino, M Taurino, F Frisenda… - RESPIRATORY …, 2017 - iris.uniroma1.it
Background Randomized Controlled Trials showed that omalizumab exhibited a good safety
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …
Long-term" real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
D Di Bona, I Fiorino, M Taurino… - Respiratory …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Randomized Controlled Trials showed that omalizumab exhibited a good safety
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …
and tolerability profile in patients with moderate-to-severe asthma. However, safety data of …